Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Blocking PAI-1 inhibits experimental PTSD development

Dec. 29, 2021

Searching for novel tricyclic M4 PAM scaffolds with improved pharmacological properties

Dec. 28, 2021

Phages help to combat bacteria, reduce antibiotic use

Dec. 27, 2021

Trinuero, DGMIF identify SERT, NET and DAT inhibitors

Dec. 24, 2021

CSIPI and Shanghai Zhongze Therapeutics patent dopamine D2/D3/5-HT2A receptor antagonists

Dec. 24, 2021

Yumanity Therapeutics discloses PIKfyve inhibitors

Dec. 23, 2021

Autobahn Therapeutics divulges new thyromimetic compounds

Dec. 23, 2021

Discovery of novel chalcone derivatives for the treatment of neurodegenerative disorders

Dec. 22, 2021

Discovery of a familial intracranial aneurysm gene

Dec. 22, 2021

OAB-14 restores dysfunction of endosomal-autophagic-lysosomal pathway in APP/PS1 mice

Dec. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...